JK

John Korukonda

Director Director DIN 08207719
DIN 08207719 First appointment Aug 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2018
Shareholding value Locked Premium profile

About John Korukonda

Data last updated:

John Korukonda has 8 years in corporate governance. Formerly with 1 company, such as Eilis Health Care Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 08207719
Primary Designation Director
First Appointment 27 Aug 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Eilis Health Care Private Limited U74999MH2018PTC313069
Director27 Aug 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eilis Health Care Private Limited
Premium access

Shareholding and investment profile for John Korukonda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Korukonda

John Korukonda has 8 years in corporate governance. Formerly with 1 company, such as Eilis Health Care Private Limited. Engaged in Healthcare. Contributes to corporate operations.

John Korukonda is associated with 0 companies as a director.

John Korukonda has expertise in Healthcare.

John Korukonda has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available